Paralisia facial unilateral: aspectos clínicos e principais tratamentos

Carvalho, Viviane Araújo e Silva de; Silva, Taynara Souza; Melo, Maria Amélia Miranda de Oliveira; GUERREIRO, N.G.; FONTOURA, J.S.; Silva, Cláudio Herbert Nina e

doi:10.34119/bjhrv3n2-036

Cited by 3 publications

(4 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The facial canal runs over the tympanum box and is through which it leaves the skull (forame estilomastoide). Within the facial canal are born the following branches: a) large petrous nerve (secret pre-loglinic fibers for the lacrimal, nasal and palatine glands); b) stoering nerve (inherbs the homonymous muscle of the middle ear); and c) tympanum cord (flavor fibers of the two thirds preceding the tongue and preganglionic fibers of the sublingual and submandibular glands) [8] .…”

Section: Main Approaches To Facial Palsymentioning

confidence: 99%

“…Occasionally ipsilateral otalgia sensory changes may occur. Another possible accompanying symptom is Epiphora, produced by the inability to lower the eyelid and drag the tear along the surface of the cornea, a fact that can influence the protection of the eyes, making the eye more susceptible to ulcers [8] .…”

Section: Main Approaches To Facial Palsymentioning

confidence: 99%

“…This will make you suspect that it is an idiopathic PFP your rapid establishment, less than 48h of evolution, exploration of the normal head, neck and ear and recovery of facial muscle mobility in a maximum of six weeks. On the contrary, it will lead to a possibly non-idiopathic PFP an establishment of the slow and progressive clinical picture, with the presence of spasms before paralysis, involvement of a single branch or bilateral involvement and lack of recovery in six weeks [8] .…”

Section: Peripheralmentioning

confidence: 99%

See 2 more Smart Citations

Application of Botulinum Toxin in Facial Paralysis

Macedo

Ramos

2022

Int J Innov Educ Res

View full text Add to dashboard Cite

Botulinum toxin (BT) considered a potent substance with high potential in several treatments, has also been gaining space in dental clinics for the treatment of various pathologies, is safe when used in appropriate doses and contraindications are respected. Before starting BT therapy, it is necessary to communicate the patient about all the potentialities and limitations of treatment. The toxin has become an efficient option for the treatment of facial paralysis (FP), a pathology that causes contraction in the facial muscles, causing temporomandibular dysfunction, damage to the process of eating food and liquids, as well as aesthetic constraints, compromising the patient's quality of life. The objective was to present the application of BT as a therapeutic option in FP. This is a review with qualitative data researched in PubMed, VHL, SciELO and LILACS. Seventy-two studies were found, excluding 27 that were outside the inclusion criteria, and 45 studies were selected. It was found that the first step to its use is to analyze the patient, evaluating the facial resuscitation procedure, defining the possibility of reversal or considerable improvement. Subsequently, it is essential to determine the cause of paralysis, its duration and the functional deficits that the patient presents, after establishing the cause, its indication is evaluated. It is essential that an individualized evaluation is always performed, proposing a realistic therapy, and making the patient aware that it is a temporary treatment. The medical literature also shows a positive effect for the use of BT in the treatment of FP, improving the quality of life, especially the patient's self-esteem.

show abstract

Section: Main Approaches To Facial Palsymentioning

confidence: 99%

Section: Main Approaches To Facial Palsymentioning

confidence: 99%

Section: Peripheralmentioning

confidence: 99%

See 1 more Smart Citation

Application of Botulinum Toxin in Facial Paralysis

Macedo

Ramos

2022

Int J Innov Educ Res

View full text Add to dashboard Cite

show abstract

“…A paralisia facial periférica ocorre como manifestação inicial em 30 a 50% dos doentes com SMR. Clinicamente é indistinguível da paralisia de Bell 15 , tendo habitualmente uma instalação súbita ou, raramente, de forma gradual em 24 a 48 horas, com resolução completa ao fim de algumas semanas 7 . Embora, no início seja intermitente, pode tornar-se persistente 7 .…”

unclassified

Síndrome de Melkersson-Rosenthal complicada com hemiespasmo facial e hipertensão intracraniana / Melkersson-Rosenthal syndrome complicated with facial hemiaspasm and intracranial hypertension

Arantes

Pretti

Lee

et al. 2020

BJHR

View full text Add to dashboard Cite

show abstract

Paralisia de Bell como complicação de otite média crônica: um relato de caso

Bazzo,

Henicka,

Espósito

2023

Revista Científica Multidisciplinar Núcleo do Conhecimento

View full text Add to dashboard Cite

O presente estudo teve como objetivo descrever um relato de caso de paralisia de Bell associada à otite média. Foi relatado o caso de uma paciente do sexo feminino, 29 anos, atendida em um hospital otorrino de Cuiabá, Mato Grosso, a qual deu entrada apresentando desvio súbito de comissura labial a direita. Nos primeiros 7 sete dias houve evolução do quadro de paralisia e piora do auditivo. As condutas adotadas para o caso foram limpeza completa do canal auditivo com remoção cuidadosa de tecido de granulação, antibioticoterapia e administração de corticoides tópicos. Após 4 dias a paciente evoluiu para recuperação significativa dos movimentos faciais e diminuição da otorreia, tendo sido observada, apenas, leve secreção em caixa média. Reflete-se sobre a importância da multidisciplinaridade no tratamento da paralisia de Bell, bem como a continuidade do acompanhamento dos pacientes, diante das possíveis sequelas da paralisia, bem como em relação às ocorrências de otite média crônica. Espera-se, por fim, que os resultados desse trabalho possam subsidiar outras investigações sobre paralisia facial associadas e doenças auditivas.

show abstract

Paralisia facial unilateral: aspectos clínicos e principais tratamentos

Cited by 3 publications

References 3 publications

Application of Botulinum Toxin in Facial Paralysis

Application of Botulinum Toxin in Facial Paralysis

Síndrome de Melkersson-Rosenthal complicada com hemiespasmo facial e hipertensão intracraniana / Melkersson-Rosenthal syndrome complicated with facial hemiaspasm and intracranial hypertension

Paralisia de Bell como complicação de otite média crônica: um relato de caso

Contact Info

Product

Resources

About